Ignite Creation Date:
2025-12-24 @ 2:03 PM
Ignite Modification Date:
2025-12-27 @ 9:40 PM
Study NCT ID:
NCT03906695
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-20
First Post:
2019-04-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes
Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-05
First Submit QC Date:
None
Study First Post Date:
2019-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-17
Last Update Post Date:
2025-03-20
Last Update Post Date Type:
ACTUAL